1315 Capital Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, 1315 Capital has acquired 1 company. It has also invested in 4 others.

1315 Capital’s most common sectors for investment aremedical products (35%) and life science (25%) . The Firm’s most common investment types include growth capital (30%) and venture (30%). In total, 1315 Capital has invested in 8 US states and 3 different countries.

In the last 3 years, 1315 Capital has exited 2 companies. The Firm’s most common exit type is trade sale (75%). 1315 Capital’s largest (disclosed) exit occurred in 2023 when it sold Verogen for $150M.

Join Mergr to view 1315 Capital’s full profile and discover more small growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity24
    • M&A Buy Activity20
    • M&A Sell Activity4
  • Total Sectors Invested 8
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 14

1315 Capital

2929 Walnut Street, Suite 1240,
Philadelphia, Pennsylvania 19104
United States
(215) 662-1315
www.1315capital.com

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.


Investment Criteria

Sectors of Interest: Consumer Products, Healthcare Services, Information Technology, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada

Transaction Criteria Min Max
Target Revenue 50 150
Target EBITDA - -
Investment Size 10 40
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.6/yr) # 12 3 2 2 - 1 20
Sell (0.6/yr) # 1 1 - 1 1 - 4
vol $126M $150M $276M
  24

Most Recent M&A

Company Date Value Type
Primrose Bio, Inc. 2024-06-17 - Growth Capital
San Diego, California · www.primrosebio.com
Verogen, Inc. 2023-01-09 150M USD Trade Sale
San Diego, California · www.verogen.com
Biocoat, Inc. 2022-11-02 - Secondary Sale
Horsham, Pennsylvania · www.biocoat.com
Innovative ECMO Concepts Inc. 2022-10-04 - Growth Capital
Arcadia, Oklahoma · www.innovativeecmo.com
Nutrisense 2022-07-13 - Venture
Chicago, Illinois · www.nutrisense.io
Homestead Smart Health Plans LLC 2021-09-30 - Growth Capital
Philadelphia, Pennsylvania · www.homesteadplans.com
miraDry, Inc. 2021-05-11 - Divestiture
Santa Clara, California · www.miradry.com
Centurion Service Group 2020-12-02 - Trade Sale
Franklin Park, Illinois · www.centurionservice.com
ProSciento 2020-09-10 - Growth Capital
San Diego, California · www.prosciento.com
Centurion Service Group 2020-02-10 - Buyout (LBO, MBO, MBI)
Franklin Park, Illinois · www.centurionservice.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 5 (33%) - 7 (35%) -
Life Science 4 (27%) - 5 (25%) -
Consumer Products 2 (13%) - 2 (10%) -
Healthcare Services 1 (7%) - 2 (10%) -
Chemicals - - 1 (5%) -
Education 1 (7%) - 1 (5%) -
Insurance 1 (7%) - 1 (5%) -
Internet Software and Services 1 (7%) - 1 (5%) -
Total 15 - 20 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 13 (87%) - 18 (90%) -
  California 4 (27%) - 6 (30%) -
  Pennsylvania 2 (13%) - 4 (20%) -
  New Jersey 2 (13%) - 2 (10%) -
  Illinois 1 (7%) - 2 (10%) -
  Maryland 1 (7%) - 1 (5%) -
  Arizona 1 (7%) - 1 (5%) -
  Oklahoma 1 (7%) - 1 (5%) -
  New York 1 (7%) - 1 (5%) -
Canada 1 (7%) - 1 (5%) -
  Ontario 1 (7%) - 1 (5%) -
Germany 1 (7%) - 1 (5%) -
Total 15 - 20 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 6 (40%) - 6 (30%) -
Venture 5 (33%) - 6 (30%) -
Buyout (LBO, MBO, MBI) 1 (7%) - 4 (20%) -
Divestiture 1 (7%) - 2 (10%) -
Stake Purchase 2 (13%) - 2 (10%) -
Total 15 - 20 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (50%) 276M (100%)
Secondary Sale 1 (25%) -
Trade Sale 1 (25%) -
Total 4 $276M

Deal Values

sell # Total
$100M to $1B 2 $276M
TOTAL $276M
Largest Verogen, Inc.
$150M (2023-01-09)

M&A Connections

Deals
Acquired from
Strategic(s)
10%
2 (10%)
Exited to
Investor(s)
25%
1 (25%)
Strategic(s)
75%
3 (75%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Small

Established

2014

Specialist/Generalist

Specialist

Leadership

Adele Oliva

Founding Partner

Michael Koby

Founding Partner

Brian Schwenk

CFO & CCO

Edward Chan

Partner

Jessica Hou

Partner

FAQ

When was 1315 Capital founded?

1315 Capital was founded in 2014.

What type of investor is 1315 Capital?

1315 Capital is a growth capital firm.

Where is 1315 Capital headquartered?

1315 Capital is headquartered in Philadelphia, Pennsylvania.

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal